Title of Collaborative Activity: |
Liquid Biopsy Working Group (LBWG) |
Description of Collaborative Activity: |
This transagency work group meets monthly to review progress in liquid biopsy toward early detection of cancer. Members from several NCI Divisions and Offices, CMS and FDA participate in the meeting. As part of this committee, experts from the extramural community are invited to speak about latest progress in liquid biopsy. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
2021 |
NIH Participating Institutes/Centers/Office of the Director: |
|
HHS Agency Collaborators on this Activity: |
CMS, FDA |
